Healthcare provider profile · identity verified

Nicolas Johnson, M.D.

Family Practice · HILLSBORO, OR · NPI 1528441318

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	250	72
Losartan Potassium	Losartan Potassium	154	39
Lisinopril	Lisinopril	146	46
Gabapentin	Gabapentin	141	36
Amlodipine Besylate	Amlodipine Besylate	126	38
Levothyroxine Sodium	Levothyroxine Sodium	111	40
Omeprazole	Omeprazole	101	32
Metformin Hcl	Metformin Hcl	91	27
Metoprolol Succinate	Metoprolol Succinate	83	23
Eliquis	Apixaban	81	20
Rosuvastatin Calcium	Rosuvastatin Calcium	80	20
Trazodone Hcl	Trazodone Hcl	79	22
Sertraline Hcl	Sertraline Hcl	75	16
Hydrochlorothiazide	Hydrochlorothiazide	64	19
Furosemide	Furosemide	57	13
Simvastatin	Simvastatin	55	14
Tamsulosin Hcl	Tamsulosin Hcl	55	21
Pantoprazole Sodium	Pantoprazole Sodium	53	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	12
Finasteride	Finasteride	44	12
Alendronate Sodium	Alendronate Sodium	43	15
Carvedilol	Carvedilol	42	12
Albuterol Sulfate Hfa	Albuterol Sulfate	38	18
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Potassium Chloride	Potassium Chloride	34	13
Clonazepam	Clonazepam	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	13
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Metformin Hcl Er	Metformin Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Ozempic	Semaglutide	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Dilt-Xr	Diltiazem Hcl	17	suppressed
Famotidine	Famotidine	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Torsemide	Torsemide	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Emgality Syringe	Galcanezumab-Gnlm	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Baclofen	Baclofen	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error